Dr. van Deutekom is the scientific co-founder of VICO Therapeutics and has an extensive track record in RNA modulating therapeutics. She has served as VP of Drug Discovery at BioMarin Pharmaceutical Inc. and as Site Head of BioMarin Nederland from 2015-2019 and was CSO at Prosensa Therapeutics B.V. from 2007-2015.
She was one of the pioneers of the application of antisense oligonucleotides and the exon-skipping technology for Duchenne Muscular Dystrophy (DMD) and has an extensive track record in the (pre)clinical development of antisense oligonucleotides for rare neuromuscular and neurodegenerative diseases since 1998. She is (co)inventor of more than 15 patent families in that field.
Current role
AI Scientist at Ekkel AI
Research Scientist at Mazumdar Shaw Medical Foundation (MSMF)
Research Resources Team Member at Australian Medical Students' Association
Data Science Vice President at PS AI Labs
Co-founder & CEO At 369 Labs | Beat Energy at Embertec
Access the worlds's biggest network of public org charts
Learn more